Bert N. van Geel

994 total citations
17 papers, 786 citations indexed

About

Bert N. van Geel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Bert N. van Geel has authored 17 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Biomedical Engineering. Recurrent topics in Bert N. van Geel's work include Cutaneous Melanoma Detection and Management (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Bert N. van Geel is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Bert N. van Geel collaborates with scholars based in Netherlands and United States. Bert N. van Geel's co-authors include Bin B. R. Kroon, Joost M. Klaase, Caroline Seynaeve, Jan G.M. Klijn, Arthur R. Van Gool, Aad Tibben, Hanne Meijers-Heijboer, Curt W. Burger, Conny A. van der Meer and J. W. Wladimiroff and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Bert N. van Geel

17 papers receiving 762 citations

Peers

Bert N. van Geel

ONCOL

GENET

PRM

PFM

David Geffen Israel

C. Bethan Powell United States

Geraldine R. Vink Netherlands

Hind Mrabti Morocco

Lisa M. Kopp United States

Janine Bell United Kingdom

Judith K. Sato United States

Jeffrey Davis Canada

Dongyan Cao China

Deborah Marcellus United States

David Geffen Israel

Bert N. van Geel

396 ×0.9

ONCOL

154 ×0.6

GENET

175 ×1.0

PRM

296 ×1.7

182 ×1.3

PFM

Citations per year, relative to Bert N. van Geel Bert N. van Geel (= 1×) peers David Geffen

Countries citing papers authored by Bert N. van Geel

Since Specialization

Citations

This map shows the geographic impact of Bert N. van Geel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert N. van Geel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert N. van Geel more than expected).

Fields of papers citing papers by Bert N. van Geel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert N. van Geel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert N. van Geel. The network helps show where Bert N. van Geel may publish in the future.

Co-authorship network of co-authors of Bert N. van Geel

This figure shows the co-authorship network connecting the top 25 collaborators of Bert N. van Geel. A scholar is included among the top collaborators of Bert N. van Geel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert N. van Geel. Bert N. van Geel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Bleiker, Eveline M. A., Marian B. E. Menke‐Pluymers, Arthur R. Van Gool, et al.. (2009). Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy. Hereditary Cancer in Clinical Practice. 7(1). 6–6. 20 indexed citations

Dalen, Thijs van, A. Hennipman, Frits van Coevorden, et al.. (2004). Evaluation of a Clinically Applicable Post-Surgical Classification System for Primary Retroperitoneal Soft-Tissue Sarcoma. Annals of Surgical Oncology. 11(5). 483–490. 66 indexed citations

Noorda, Eva M., R. Bart Takkenberg, Bart C. Vrouenraets, et al.. (2004). Isolated Limb Perfusion Prolongs the Limb Recurrence-Free Interval After Several Episodes of Excisional Surgery for Locoregional Recurrent Melanoma. Annals of Surgical Oncology. 11(5). 491–499. 22 indexed citations

Seynaeve, Caroline, et al.. (2003). Low Dose Methotrexate and Vinblastine, Given Weekly to PatientsWith Desmoid Tumours, is Associated With Major Toxicity. Sarcoma. 7(3-4). 153–157. 14 indexed citations

Oostrom, Iris van, Hanne Meijers-Heijboer, Litanja Lodder, et al.. (2003). Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up Study. Journal of Clinical Oncology. 21(20). 3867–3874. 229 indexed citations

Dalen, Thijs van, J.W.W. Coebergh, M. K. Casparie, et al.. (2001). Soft Tissue Sarcoma: The Predominant Primary Malignancy in the Retroperitoneum. Sarcoma. 5(1). 5–8. 7 indexed citations

Brekelmans, Cecile T.M., Adri C. Voogd, Bert N. van Geel, et al.. (1999). Family history of breast cancer and local recurrence after breast-conserving therapy. European Journal of Cancer. 35(4). 620–626. 27 indexed citations

Vrouenraets, Bart C., Guus Hart, Alexander Eggermont, et al.. (1999). Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. Journal of the American College of Surgeons. 188(5). 522–530. 50 indexed citations

Voogd, Adri C., Geertjan van Tienhoven, Hans Peterse, et al.. (1999). Local recurrence after breast conservation therapy for early stage breast carcinoma. Cancer. 85(2). 437–446. 121 indexed citations

10.

Vrouenraets, Bart C., Bert N. van Geel, Joost M. Klaase, et al.. (1996). Systemic toxicity after isolated limb perfusion with melphalan for melanoma. European Journal of Surgical Oncology. 22(5). 521–527. 30 indexed citations

11.

Klop, W. Martin C., B. C. Vrouenraets, Bert N. van Geel, et al.. (1996). Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.. PubMed. 182(6). 467–72. 27 indexed citations

12.

Klaase, Joost M., et al.. (1994). Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities. The American Journal of Surgery. 167(6). 618–620. 35 indexed citations

13.

Wijnmaalen, Arendjan, B van Ooijen, Bert N. van Geel, Sonja C. Henzen‐Logmans, & A. D. Treurniet-Donker. (1993). Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: Three case reports and a review of the literature. International Journal of Radiation Oncology*Biology*Physics. 26(1). 135–139. 76 indexed citations

14.

Kroon, Bin B. R., et al.. (1993). Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb. European Journal of Cancer. 29(3). 325–328. 27 indexed citations

15.

Wiggers, Theo, et al.. (1990). Assessment of insertion techniques and complication rates of dual lumen central venous catheters in patients with hematological malignancies. World Journal of Surgery. 14(1). 101–104. 8 indexed citations

16.

Zee, Jacoba van der, et al.. (1989). Temperature distribution and pH changes during hyperthermic regional isolation perfusion. European Journal of Cancer and Clinical Oncology. 25(8). 1157–1163. 13 indexed citations

17.

Geel, Bert N. van, et al.. (1989). Intractible cutaneous non-Hodgkin's lymphoma of the lower limb. Complete remission after sequential regional isolated hyperthermic perfusion and perfusion with 1-phenylalanine-mustard (melphalan, L-pam). Cancer. 64(2). 392–395. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact